Brilliant Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Brilliant Therapeutics Private Limited

Brilliant Therapeutics Private Limited, a active private limited company, was established on 03 November 2016 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33112TG2016PTC112782. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Darla Prasad (Director), Puvula Kanaka Rao (Director). Past directors included Ramaswamy Natesaiyer, Chandra Sekhar Korrapati, Dinar Kumar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Fifth Floor,T.G.V. Mansion,6-2-1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, 500004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33112TG2016PTC112782

  • Registration Number

    112782

  • Incorporation Date

    03 November 2016

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Brilliant Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Brilliant Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Brilliant Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Darla Prasad Director 05 Oct 2019 Current
Puvula Kanaka Rao Director 30 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Oct 2018 Past
Pramod Abcsdd Director 05 Oct 2019 Past
Pramod Abcsdd Director 30 Mar 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Brilliant Therapeutics.

Brilliant Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Brilliant Therapeutics revenue growth over time
Brilliant Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Brilliant Therapeutics?

In 2017, Brilliant Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Brilliant Therapeutics?

Unlock and access historical data on people associated with Brilliant Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Brilliant Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brilliant Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Brilliant Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Brilliant Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Brilliant Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Darla Prasad was appointed as a Director was appointed as a Director on 05 Oct 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Puvula Kanaka Rao was appointed as a Director was appointed as a Director on 30 Mar 2017 & has been associated with this company since 9 years 2 months . was documented.

  • Company Incorporation

    The activity Brilliant Therapeutics Private Limited was registered on 03 Nov 2016 with Roc Hyderabad & aged 9 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Brilliant Therapeutics Private Limited?

The CIN of Brilliant Therapeutics Private Limited is U33112TG2016PTC112782.

Where is Brilliant Therapeutics Private Limited headquartered?

Brilliant Therapeutics Private Limited is headquartered at Fifth Floor,T.G.V. Mansion,6-2-1012 Rajbhavan Road Khairatabad, Hyderabad, Telangana, 500004.

When was Brilliant Therapeutics Private Limited incorporated?

Brilliant Therapeutics Private Limited was incorporated on 03 November 2016.

Who are the current directors of Brilliant Therapeutics Private Limited?

The current directors of Brilliant Therapeutics Private Limited are

What is the primary industry of Brilliant Therapeutics Private Limited?

The primary industry of Brilliant Therapeutics Private Limited is Manufacturing.

Is Brilliant Therapeutics Private Limited a listed company?

Brilliant Therapeutics Private Limited is unlisted.

What is the capital structure of Brilliant Therapeutics Private Limited?

The authorized capital of Brilliant Therapeutics Private Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.

What is the compliance status of Brilliant Therapeutics Private Limited?

The compliance status of Brilliant Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available